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2-Microglobulin Amyloid Fibrils Are Nanoparticles That
Disrupt Lysosomal Membrane Protein Trafficking and Inhibit
Protein Degradation by Lysosomes*
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Background: The causative agents and pathological mechanisms of amyloid disease are poorly understood.
Results: 2-Microglobulin amyloid fibrils display length-dependent internalization, alter trafficking of lysosomal membrane
proteins, and inhibit the degradation of proteins by lysosomes.
Conclusion: Amyloid fibrils act as nanoparticles that disrupt membrane trafficking and protein degradation.
Significance: Fibril length, by determining access to intracellular compartments, may contribute to amyloid disease.
Fragmentation of amyloid fibrils produces fibrils that are
reduced in length but have an otherwise unchanged molecular
architecture. The resultant nanoscale fibril particles inhibit the
cellular reduction of the tetrazolium dye 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a substrate
commonly used tomeasure cell viability, to a greater extent than
unfragmented fibrils. Here we show that the internalization of
2-microglobulin (2m) amyloid fibrils is dependent on fibril
length, with fragmented fibrils being more efficiently internal-
ized by cells. Correspondingly, inhibiting the internalization of
fragmented 2m fibrils rescued cellular MTT reduction. Incu-
bation of cells with fragmented 2m fibrils did not, however,
cause cell death. Instead, fragmented 2m fibrils accumulate in
lysosomes, alter the trafficking of lysosomal membrane pro-
teins, and inhibit the degradation of a model protein substrate
by lysosomes. These findings suggest that nanoscale fibrils
formed early during amyloid assembly reactions or by the frag-
mentation of longer fibrils could play a role in amyloid disease
by disrupting protein degradation by lysosomes and trafficking
in the endolysosomal pathway.
The amyloidoses are a class of human disorders that include
the neurological conditions Alzheimer, Parkinson, Hunting-
ton, and Creutzfeldt-Jakob diseases; the metabolic disorder
type II diabetes mellitus; and the systemic condition dialysis-
related amyloidosis (1–3). Irrespective of the sequence and
native structure of the culprit protein, amyloid fibrils share a
common characteristic cross- architecture (1, 2). In many
amyloid diseases, fibril formation is associated with cellular
dysfunction and tissue destruction, although themolecular and
cellularmechanisms of amyloid disease remain unclear (2, 4, 5).
It is imperative, therefore, to characterize species associated
with amyloid formation and to elucidate how these species
interact with cells and affect cellular function.
Numerous studies have shown that oligomeric intermediates
of amyloid assembly can be cytotoxic in vitro and in vivo (6–11)
and impair memory and long-term potentiation (12–14). By
contrast with oligomeric species, amyloid fibrils have been
shown to exhibit limited, if any, cytotoxicity (6–11) and it has
even been suggested that amyloid fibrils represent inert end
products of amyloid assembly. In other experiments, however,
some fibril samples have been shown to be cytotoxic (15–18), to
possess cytotoxic potential that is dependent on the nature of
the preparation (19–24), and, upon depolymerization, to act as
a source of cytotoxic oligomers and protofilaments (25–27).
Further evidence for a potential role for fibrils in amyloid
disease mechanisms was provided by our observations that
amyloid fibrils formed in vitro from 2-microglobulin (2m),
5
-synuclein and hen egg white lysozyme disrupt artificial lipid
membranes (28, 29). Intriguingly, nanoscale fibrils produced by
fragmentation disrupted these lipid membranes to a greater
extent than their longer unfragmented precursors (28), poten-
tially via the interaction of fibril ends with lipid bilayers (30).
Fragmented fibrils also inhibit the cellular reduction of the tet-
razolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) (28), a substrate commonly used to
assay cell viability (31). However, the precise nature of this cel-
lular perturbation and why it is dependent on fibril length
remained unclear.
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In this study, the amyloidogenic protein 2m, the causative
agent of dialysis-related amyloidosis (32), was used to investi-
gate the cellular effects of fragmented amyloid fibrils. Despite
inhibiting the cellular reduction of MTT, we show that frag-
mented 2m fibrils have no effect on cell viability. 2m fibrils
instead exhibited length-dependent uptake by cells, with frag-
mented fibrils (nanometer length) being internalized and
sorted to lysosomes to a greater extent than longer (micrometer
length) unfragmented fibrils.Moreover, fragmented2mfibrils
altered the trafficking of the lysosomal membrane proteins
LAMP-1 and CD63 and inhibited the degradation of ovalbu-
min, a model protein substrate for lysosomal proteases. These
results reveal lysosomes as a cellular target for amyloid fibrils
and suggest that nanoscale-length fibrils or species derived
from these fibrils may contribute to amyloid disease.
EXPERIMENTAL PROCEDURES
Preparation of Fibril Samples—Fibrils of human 2m were
formed from recombinant protein as described previously at a
monomer-equivalent concentration of 120M (28). Labeling of
2mwith tetramethylrhodamine (TMR,Molecular Probes)was
performed as described previously (33). TMR-labeled fibrils
were formed from a 1:9 mixture of TMR-labeled:unlabeled
2m. Fragmented fibrils were prepared by fragmenting samples
of unfragmented fibrils by stirring at 1000 rpm at 25 °C for 2
days using a custom-made precision stirrer (built by the work-
shop of the School of Physics and Astronomy, University of
Leeds, UK) (28). 2m fibril samples were imaged using atomic
force microscopy, and fibril length distributions were analyzed
as described previously (34).
Cell Culture—The SH-SY5Y neuroblastoma cell line was cul-
tured as described previously (28). Cells were incubated with
either 1.2 or 6.0 M (monomer-equivalent concentration) of
2m fibril samples or 2mmonomers for up to 48 h.
Analysis of Cell Viability—SH-SY5Y cells were cultured in
96-well plates (20,000 cells/well for MTT and WST-1 assays
and 10,000 cells/well for the ATP assay) for 24 h in 200 l of
growthmedium.Themediumwas then replaced, and2mfibril
samples or controls (fibril growth buffer or 0.1% (w/v) NaN3)
were incubated with the cells for a further 24 h. Each experi-
ment consisted typically of two to three independent experi-
ments, each containing five replicates per condition. For inhi-
bition of fibril internalization, 5 M Dynasore (Merck) was
incubated with the cells for 30 min prior to addition of fibril
samples. The MTT assay was performed as described previ-
ously (28). To assay for WST-1 metabolism, 100 l of medium
was removed from each well, and 10 l of WST-1 cell prolifer-
ation reagent (Roche) was added. Cells were then incubated for
1 h, and absorbance was read directly at 450 nm using a Pow-
erwave XS2 plate reader (BioTek). For the MTT and WST-1
assays, the results were normalized using the signal for cells
incubated with the fibril growth buffer as 100% viability, and
cells were treated with NaN3 as 0% viability. Cellular ATP was
measured with the ATPLite Luminescence ATP detection
assay system (PerkinElmer Life Sciences) according to the pro-
tocol of the manufacturer, and luminescence was measured on
a POLARstar OPTIMA plate reader (BMGLabtech). ATP con-
centrations were calculated for the volume of cell culture
medium.
Propidium Iodide Staining—5 105 SH-SY5Y cells were cul-
tured in 12-well plates for 24 h and incubated with 2m fibril
samples for 24 h. As a positive control, cells were incubated
with 600mMH2O2 for 5 h. Cells were detached from the culture
plates and incubated with 75 M propidium iodide prior to
analysis on a BD-LSRFortessa flow cytometer (BDBiosciences).
10,000 gated events were recorded for three independent
experiments, each containing three replicates per condition.
Propidium iodide-positive cells were defined as those that
stained with the dye to the same level as cells incubated with
H2O2.
Analysis of Cell-associated 2m Monomer and Fibrils—
SH-SY5Y cells were incubated with TMR-2m-labeled fibrils
or TMR-2m monomers (9:1 ratio unlabeled:TMR-labeled
protein) for 4 h. Prior to live cell imaging, cells were incubated
with 100 nM LysoTrackerGreen (Molecular Probes) for 30min.
To inhibit endocytic pathways, cells were incubated with 5 M
Dynasore for 30 min prior to incubation with fibril samples.
Imaging was performed using a Zeiss LSM510 META laser
scanning confocal microscope and an inverted AxioVert 200M
microscope with a 40 objective. The total cell-associated
TMR-2m fluorescence for 10,000 gated events was quantified
with a FACSCalibur flow cytometer (BD Biosciences).
NIAD-4 Staining of 2m Amyloid Fibrils—To measure
NIAD-4 (ICX Nomadics) binding to 2m monomer and frag-
mented fibrils in vitro at pH values of 7.4 and 4.5, samples con-
taining 12 M (monomer-equivalent concentration) of 2m
fibril samples or monomers were incubated with 7.5 M
NIAD-4 for 1 h at 25 °C. The fluorescence emission spectra of
the samples (excitation wavelength of 500 nm) were subse-
quently collected after incubation for 1 h at 25 °C using a PTI
Quantamaster fluorescence spectrometer. To detect cell-asso-
ciated amyloid fibrils, SH-SY5Y cells were incubated with 2m
samples for 16 h prior to staining with 100 nM NIAD-4 and
either 100 nM LysoTracker Deep Red (Molecular Probes) or 0.5
g/ml CellMask Deep Red plasma membrane stain (Molecular
Probes). Imaging was performed using a Zeiss LSM700 confo-
cal microscope with a 63 objective.
Analysis of Lysosome Membrane Permeability—To analyze
lysosome integrity using live cell confocal microscopy and flow
cytometry, cells were stained with 100 nM LysoTracker Green
30 min prior to analysis. As a positive control for lysosome
membrane permeabilization, cells were incubated for 15 min
with either 6 or 15 M sphingosine. Cells were imaged using a
Zeiss LSM700 confocal microscope with a 63 objective. Flow
cytometry was performed using a BD-LSRFortessa flow cytom-
eter, with 10,000 gated events recorded for three independent
experiments, each containing three replicates per condition.
For subcellular fractionation, 2  107 cells were resuspended
into 1 ml of homgenization buffer (10 mM acetic acid, 1 mM
EDTA, 190 mM sucrose, and 10 mM triethanolamine (pH 7.4)),
homogenized with a ball bearing homogenizer (Isobiotec) as
described previously (35), and centrifuged at 400 g for 10min
in a microcentrifuge to generate a postnuclear supernatant.
This was centrifuged at 100,000  g for 1 h (S100-AT3 rotor,
Sorvall). The activity of -N-acetylgalactosaminidase in the
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resultant pellet and supernatant fractions was assayed as
described previously (36).
Analysis of the Expression and Localization of LAMP-1 and
CD63—To visualize the cellular distribution of LAMP-1 and
CD63 cells by immunofluorescence microscopy, cells were
fixed and permeabilized as described previously (35) before
staining with rabbit anti-LAMP1 (Sigma-Aldrich) and mouse
anti-CD63 (clone MEM-259, AbD Serotec) antibodies. CD63
staining was detected with an anti-rabbit FITC antibody, and
LAMP1 staining was detected with an anti-mouse Texas Red
antibody (BD Biosciences). Cells were imaged using a Zeiss
LSM700 confocal microscope with a 63 objective. Cell sur-
face expression of LAMP-1 and CD63 cells was analyzed by
flow cytometry. To inhibit protein synthesis, cells were prein-
cubated for 1 hwith 100g/ml cycloheximide prior to the addi-
tion of 2m samples. Cells were then resuspended in PBS, 0.2%
BSA, and 10% Mouse Seroblock FcR (AbD Serotec) and incu-
bated for 30 min on ice. To detect cell surface expression of
LAMP-1 and CD63, cells were stained with PE-Cy5 conjugated
mouse anti-human LAMP-1 (cloneH4A3, BDBiosciences) and
FITC-conjugated mouse anti-human CD63 (clone MEM-259,
Genetex), respectively. To measure nonspecific background
antibody binding, controls were included in which cells were
stained with the PE-Cy5-conjugated mouse IgG1  (BD Biosci-
ences) and FITC-conjugated mouse IgG1 (Genetex) isotype
controls, respectively, for the LAMP-1 and CD63 antibodies.
Cell-associated antibody fluorescence was quantified by flow
cytometry with a BD-LSRFortessa, and 10,000 gated events
were recorded for three independent experiments, each con-
taining three replicates per condition. For each experimental
condition, the geometric mean fluorescence for cells stained
with the isotype controls was subtracted from the geometric
mean fluorescence for cells stainedwith the LAMP-1 andCD63
antibodies. The resultant fluorescence value was then normal-
ized to that of cells incubated for 0 h with 2m samples. The
total cellular levels of LAMP-1 and CD63 were determined by
immunoblotting of cell lysates with mouse anti-human
LAMP-1 (clone H4A3, Santa Cruz Biotechnology) and rabbit
anti-humanCD63 (cloneMX-49.129.5, SantaCruzBiotechnol-
ogy) antibodies, respectively. Immunoblots were also probed
with a GAPDH antibody (clone 6C5, Abcam) as a loading
control.
Analysis of the Lysosomal Degradation of Ovalbumin—After
incubation with 2m samples for 24 h, cells were washed and
incubated for 6 h with 15 g/ml ovalbumin, which corre-
sponded to a 2:3 mixture of ovalbumin-Alexa Fluor 647 (Ova-
647, Molecular Probes):unlabeled ovalbumin. Cells were then
washed to remove non-cell-associated ovalbumin and either
imaged or incubated for a further 24 h before imaging. Prior to
imaging, lysosomes were stained with 100 nM LysoTracker
Green and viewed with a Zeiss LSM700 confocal microscope
with a 63 objective. Total cell-associated Ova647 fluores-
cence was quantified by flow cytometry with a BD-LSRFortessa
(BD Biosciences), and 10,000 gated events were recorded for
three independent experiments, each containing three repli-
cates per condition.
Analysis of the Activity of Lysosomal -Glucocerebrosidase
and -Galactosidase—After incubation with 2m samples for
24 h, cells were washed and incubated with either 58 M 5-
(pentafluorobenzoylamino)fluorescein di--D-glucopyrano-
side (Invitrogen) or 33M 5-dodecanoylaminofluorescein di--
D-galactopyranoside (C12FDG, Invitrogen) for 1 h at 37 °C.
-glucocerebrosidase cleaves the non-fluorescent substrate
5-(pentafluorobenzoylamino)fluorescein di--D-glucopyrano-
side to yield the green-fluorescent 5-(pentafluorobenzoylami-
no)fluorescein dye, whereas -galactosidase cleaves the non-
fluorescent substrate C12FDG to yield fluorescent fluorescein
that can be detected by flow cytometry (37, 38). As a control,
cells were preincubated for 1 h with 1 M conduritol B epoxide
(Sigma-Aldrich) and 1mM phenylethyl-D-thiogalactopyrano-
side (Invitrogen) to inhibit the activities of -glucocerebrosi-
dase and -galactosidase, respectively (39, 40). Cell-associated
fluorescence was quantified with a BD-LSRFortessa flow
cytometer, and 10,000 gated events were recorded for two inde-
pendent experiments, each containing three replicates per
condition.
Statistical Analysis—p values were determined using two-
tailed independent two-sample Student’s t test between sample
pairs.
RESULTS
Fragmented 2m Fibrils Inhibit Cellular MTT Reduction but
Do Not Cause Cell Death—Incubation of 2m at pH 2.0 under
quiescent conditions results in the formation of straight and
twisted amyloid-like fibrils (Fig. 1A) that closely resemble those
present in ex vivo amyloid deposits (32, 41–43). These fibrils
were then fragmented with a precision stirrer (Fig. 1A) (28),
reducing the average fibril length from 1.3 m to 300 nm
(Fig. 1B). Fragmentation of 2m fibrils does not generate spe-
cies that are detected by the oligomer-specific antibody A11 (6,
28), but they retain their structural integrity, as judged by Fou-
FIGURE 1. Atomic force microscopy characterization of 2m fibrils. A,
atomic force microscopy images of unfragmented and fragmented 2m
fibrils. Scale bars  1 m (main images) and 250 nm (insets). B, fibril length
distributions. The average fibril length was calculated from 200 particles to
be 1.30  0.05 m and 0.30  0.01 m for the unfragmented and fragmented
fibrils, respectively.
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rier transform infrared spectroscopy and the ability to bind the
amyloid-specific antibody WO1 (28). All subsequent experi-
ments were performed with fibril samples of these lengths.
The effect of the fibrils on the neuroblastoma cell line
SH-SY5Y was then analyzed using an MTT assay. In this pro-
cedure, cellular reduction of the tetrazolium dye MTT is mea-
sured, and this assay can be used as an indicator of cell viability
(31). As reported previously (28), fragmented 2m fibrils inhib-
ited the reduction of MTT to a greater extent than either
unfragmented fibrils or fibril growth buffer (Fig. 2A). Studies
examining the cellular mechanism of MTT reduction have
shown that MTT is reduced to produce an insoluble colored
formazan salt that localizes to intracellular granule-like struc-
tures before being exocytosed to the cell surface, where it forms
needle-like crystals (31, 44). Other amyloidogenic sequences,
A1–40 and amylin, greatly increase the proportion of reduced
MTT formazan present in these extracellular needle-like crys-
tals by increasing the exocytosis of MTT formazan (45–47).
Analysis of SH-SY5Y cells revealed that MTT formazan was
present in intracellular punctate structures in cells incubated
with fibril growth buffer, whereas cells incubated with 2m
fibrils exhibited a marked increase in extracellular needle-like
crystals of reducedMTT formazan (Fig. 2B). These data suggest
that the inhibition ofMTT reduction by fragmented2m fibrils
may result from increased secretion of the MTT reduction
product, which, in turn, may inhibit cellular uptake of MTT
(45–47).
To determine whether the inhibition of cellularMTT reduc-
tion by fragmented 2m fibrils corresponds to a loss of cell
viability, cellular ATP levels were assayed. No pronounced
decrease in cellular ATP levels was observed in SH-SY5Y cells
incubated with either fragmented or unfragmented fibrils (Fig.
3A). The effect of fibrils on reduction of the tetrazolium salt
WST-1 was also assayed. In contrast toMTT, which is reduced
intracellularly, WST-1 reduction is thought to occur at the
plasma membrane (31, 44). Fragmented 2m fibrils had no sig-
nificant effect on the reduction of WST-1 by SH-SY5Y cells
(Fig. 3B), suggesting that the overall reductive capacity of the
cells is not diminished. Staining of cells with the plasma mem-
brane-impermeable dye propidium iodide is indicative of cells
that have undergone necrosis or late-stage apoptosis (48). No
significant increase in the percentage of cells stained with pro-
pidium iodide was observed when cells were incubated with
fragmented2m fibrils for 24 h (Fig. 3,C andD), indicating that
the plasma membrane is intact in fibril-treated cells. Taken
together, these data demonstrate that fragmented 2m fibrils
do not have a significant effect on cell viability. Nonetheless, the
inhibition ofMTT reduction suggests that2m fibrils do have a
length-dependent effect on some facet of cellular physiology.
2m Fibrils Exhibit Length-dependent Internalization, and
the Inhibition of Fibril Uptake Rescues the Cellular Reduction of
MTT—Wehave shown previously that 2m fibrils are internal-
ized and trafficked to lysosomes and that they are resistant to
lysosomal proteolysis (33, 49). We therefore investigated the
relationship between fibril length, fibril trafficking to lyso-
somes, and the inhibition of MTT reduction. SH-SY5Y cells
were incubated for 4 h with either TMR-labeled monomeric
2m or fibrils that incorporate TMR-labeled 2m, and the
localization of the fluorescently labeled protein was visualized
using live cell confocal microscopy. Consistent with the known
uptake and degradation of monomeric 2m within lysosomes
(33, 49), cells incubated with TMR-labeled monomeric 2m
exhibited intracellular TMR fluorescence that colocalized in
part with LysoTracker Green (Fig. 4A), a dye that accumulates
in acidic compartments. Cells incubated with unfragmented
fibrils had limited intracellular TMR-associated fluorescence.
The fibrils were instead localized predominantly in close prox-
imity to the extracellular side of the plasma membrane (Fig.
4A). Conversely, cells incubated with TMR-labeled fragmented
2m fibrils displayed more extensive intracellular punctate
fluorescence that colocalized with LysoTracker Green (Fig.
4A). Quantification of intracellular TMR-2m fluorescence
revealed a 5-fold increase in intracellular 2m in cells incu-
bated with fragmented fibril samples compared with cells incu-
batedwith unfragmented fibrils (Fig. 4B). By contrast, total cell-
associated fluorescence, measured by flow cytometry, was
comparable for cells incubated with either TMR-labeled frag-
mented or unfragmented fibrils (Fig. 4C).
FIGURE 2. Fragmented fibrils of 2m inhibit the cellular reduction of MTT.
A, SH-SY5Y cells were incubated for 24 h with 1.2 M (monomer-equivalent
concentration) fragmented or unfragmented 2m fibrils, and the reduction of
MTT was assayed. The percentage of MTT reduction relative to control cells
incubated with the fibril growth buffer was plotted. The error bars represent
mean  1 S.E. over a total of 15 replicates. ***, p  0.001. B, cells incubated
with MTT were imaged by phase-contrast microscopy to visualize the
reduced MTT formazan (dark staining). Scale bar  20 m.
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To determine whether 2m fibrils retain an amyloid archi-
tecture after internalization, SH-SY5Y cells incubated with
unlabeled 2m fibrils were stained with the amyloid-specific
dye NIAD-4 (50). In vitro experiments showed that the fluores-
cence intensity of NIAD-4 increases upon binding to 2m
fibrils at both pH 7.5 (the pH of culture medium and the cyto-
sol) and pH 4.5 (lysosomal pH) but not when NIAD-4 is incu-
bated with monomeric 2m at either pH (Fig. 5A). Likewise, no
staining with NIAD-4 was observed for cells incubated with
monomeric 2m (Fig. 5, B and C). Punctate NIAD-4 fluores-
cence was observed for cells incubated with fragmented 2m
fibrils that colocalized with LysoTracker Far Red staining (Fig.
5B), consistent with their internalization and the resistance of
2m fibrils to digestion by lysosomal proteases (49). However,
for cells incubated with unfragmented fibrils, NIAD-4 fluores-
cence was localized predominantly in proximity to the plasma
membrane labeled with CellMask Far Red (Fig. 5C). These data
demonstrate that, by reducing fibril length, fragmentation
enables increased trafficking of 2m fibrils to lysosomes and
that these cell-associated 2m fibrils retain, at least in part, a
cross- architecture.
The above results suggest a direct relationship between the
level of 2m fibril internalization and the effect of fibrils on the
cellular reduction ofMTT. To confirmwhether this is the case,
the effect of inhibiting endocytic pathways on the reduction of
MTT by fibril-treated cells was examined. SH-SY5Y cells were
incubated with Dynasore, an inhibitor of dynamin-dependent
endocytosis (51), and the effects on fibril uptake and MTT
metabolism were monitored using confocal microscopy and
the MTT assay, respectively. Dynasore inhibited the internal-
ization of 2m fragmented fibrils by SH-SY5Y cells (Fig. 6A)
and partially rescued the inhibition of MTT reduction by 2m
fibrils (Fig. 6B). Correspondingly, Dynasore decreased, in part,
the formation of extracellular needle-like crystals of reduced
MTT formazan by cells incubated with 2m fibrils (Fig. 6C).
Therefore, these data suggest that access to intracellular com-
partments via dynamin-dependent endocytosis is required for
the 2m fibril-associated effects on cellular function measured
in the MTT assay.
Fragmented 2m Fibrils Do Not Increase Lysosome Mem-
brane Permeability—In previous work, we have shown that
fragmented 2m fibrils interact with and disrupt artificial lipid
membranes and that this is enhanced by endosomal lipids and
an acidic pH (28–30, 52). We therefore examined whether the
internalization of 2m fibrils results in an increase in the per-
meability of the lysosomal membrane. Sphingosine, a positive
FIGURE 3. Fragmented fibrils of 2m do not reduce cell viability. A and B, SH-SY5Y cells were incubated for 24 h with 1.2 M (monomer-equivalent
concentration) fragmented or unfragmented 2m fibrils, and the cellular level of ATP (A) and the reduction of WST-1 were assayed (B). The ATP concentration
and the WST-1 signal relative to control cells incubated with the fibril growth buffer were plotted. The error bars represent mean  S.E. over a total of 15 (ATP)
and 10 (WST-1) replicates. NS, p  0.05. SH-SY5Y cells were stained with propidium iodide (PI) after 24 h incubation with either 2m fragmented or unfrag-
mented fibrils and analyzed by flow cytometry. H2O2, which increases plasma membrane permeability, was used as positive control. C, representative flow
cytometry profiles. AU, arbitrary units. D, the percentage of propidium iodide-stained cells was plotted. The error bars represent mean  1 S.E. over a total of
nine replicates.
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control, known to permeabilize the lysosomal membrane (53),
caused a significant reduction in the cell-associated fluores-
cence of cells stainedwith LysoTrackerGreenwhen either visu-
alized by live cell confocal microscopy or quantified by flow
cytometry (Fig. 7, A and B). In contrast, fragmented 2m fibrils
did not reduce the LysoTrackerGreen staining of cells (Fig. 7,A
and B). Even when cells were incubated for 48 h with 6.0 M
(monomer-equivalent concentration) of fragmented 2m
fibrils, no reduction in LysoTracker staining was detected (Fig.
7, A and B), therefore suggesting that fibrils do not increase
permeability of the lysosomal membrane. Increased lysosome
membrane permeability may also release soluble lysosomal
hydrolases into the cytosol. SH-SY5Y cells were therefore incu-
bated with fragmented 2m fibrils and fractionated by centrif-
ugation into soluble (cytosol) and pellet (membrane) fractions.
In both control cells and cells incubated with fragmented 2m
fibrils, activity of the lysosomal hydrolase -N-acetylgalac-
tosaminidase was present predominantly in the membrane-
fraction, with negligible activity in the cytosol fraction (Fig. 7C).
Therefore, these experiments provide no evidence that frag-
mented 2m fibrils cause substantive damage to the lysosome
membrane.
Fragmented 2m Fibrils Increase the Cell Surface Expression
of Lysosomal Membrane Proteins—To explore in more detail
the impact of fragmented fibrils on lysosomes, we examined
whether there was an alteration in the trafficking of the lyso-
somal membrane proteins LAMP-1 and CD63. LAMP-1 and
CD63 exhibited a punctate distribution in untreated cells that
FIGURE 4. Fragmented fibrils of 2m are internalized and accumulate in lysosomes. A, SH-SY5Y cells were incubated with 1.2 M (monomer-equivalent
concentration) TMR-labeled fragmented or unfragmented 2m fibrils or 1.2 M TMR-labeled 2m monomers for 4 h. Labeled samples contained 10% TMR-
labeled 2m and 90% unlabeled monomer. Prior to imaging, the lysosomes were stained with the lysotrophic dye LysoTracker Green. Cell-associated fluores-
cence was visualized by live cell confocal microscopy. TMR, Lysotracker Green, and phase-contrast images are shown individually and merged. In the merged
images, yellow is indicative of colocalization of the TMR-labeled 2m and the LysoTracker Green dye. Scale bar  10 m. B, the mean pixel intensity of
intracellular TMR-labeled 2m within SH-SY5Y cells was quantified from the confocal microscopy images for 60 cells. The data were normalized to the pixel
count of samples incubated with fragmented fibrils. The error bars represent mean  S.E. C, total cell-associated TMR fluorescence was quantified by flow
cytometry. AU, arbitrary units.
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was not altered substantially in cells that were incubated with
either fragmented 2m fibrils or with 2mmonomers (Fig. 8A).
Immunoblotting of whole cell lysates also showed that levels of
LAMP-1 and CD63 were comparable for cells incubated in the
absence of 2m, with monomeric protein, or with fibrils (Fig.
8B). However, flow cytometry revealed that the incubation of
cells with fragmented 2m fibrils resulted in increased cell sur-
face expression of both LAMP-1 and CD63 in comparison with
cells incubated with 2mmonomers (Fig. 8C). These data indi-
cate that fragmented 2m fibrils cause the redistribution of a
subpopulation of LAMP-1 and CD63 to the plasmamembrane.
This could result from the trafficking of preexisting pools of
these proteins to the plasma membrane, as would occur in lys-
osome exocytosis (54). Alternatively, an increased proportion
of newly synthesized LAMP-1 and CD63 may traffic to, or be
retained at, the plasmamembrane (54, 55). Cells were therefore
incubated with the protein synthesis inhibitor cycloheximide
prior to the addition of fragmented 2m fibrils. This resulted in
a reduction in the cell surface expression of LAMP-1 and CD63
(Fig. 8D), suggesting that a significant proportion of LAMP-1
and CD63 on the surface of cells incubated with the fibrils cor-
responds to newly synthesized protein.
Fragmented 2m Fibrils Inhibit Lysosomal Proteolysis—
Finally, to determine whether fragmented 2m fibrils disrupt
the function of lysosomes, we assayed the cleavage of substrates
for lysosomal hydrolases in SH-SY5Y cells. The capacity of lyso-
somes to degrade proteins was studied bymeasuring the prote-
olysis of ovalbumin, a protein that is endocytosed and degraded
in lysosomes (56). Cells that had been preincubated with either
monomeric 2m or fragmented fibrils were incubated with
Ova-647, ovalbumin labeled with the fluorescent dye Alexa
Fluor 647. Imaging experiments revealed that Ova-647 was
internalized and sorted into punctate compartments that
costained with LysoTracker Green (Fig. 9A). Cells were then
washed to remove non-cell-associated Ova-647 and incubated
for a further 24-h chase period prior to analysis. Cell-associated
Ova-647 at the end of the chase period was visualized by con-
focal microscopy (Fig. 9B) and quantified by flow cytometry
(Fig. 9, C and D). After the 24-h chase, cells preincubated with
monomeric 2mhad a pronounced reduction in cell associated
Ova-647, 15% of that present at 0 h chase (Fig. 9, B–D). This
was presumably due to the degradation of ovalbumin by lyso-
somal proteases (56). Cells preincubated with fragmented 2m
fibrils, by contrast, had a significantly higher level of cell-asso-
ciated Ova-647 after the 24-h chase, corresponding to45% of
that present at 0 h chase (Fig. 9, B–D). These data suggest,
therefore, that amyloid fibrils impair the ability of SH-SY5Y
cells to degrade endocytosed proteins.
To determine whether the activity of other lysosomal hydro-
lases was affected by fragmented 2m fibrils, the cellular activ-
ities of the glycosidases -glucocerebrosidase and -galactosi-
dase were assayed by flow cytometry using the substrates
5-(pentafluorobenzoylamino)fluorescein di--D-glucopyrano-
side and C12FDG, respectively (37, 38). The -glucocerebrosi-
dase inhibitor conduritol B epoxide, but not fragmented 2m
fibrils, caused a significant reduction in the hydrolysis of
5-(pentafluorobenzoylamino)fluorescein di--D-glucopyrano-
side by SH-SY5Y cells (Fig. 10A). The hydrolysis of C12FDGwas
reduced by the -galactosidase inhibitor phenylethyl -D-thio-
galactopyranoside, whereas incubation of cells with frag-
mented 2m fibrils resulted in a small reduction in substrate
hydrolysis (Fig. 10B). Therefore, fragmented 2m fibrils inhibit
the lysosomal degradation of ovalbumin but have a less pro-
nounced effect on the cleavage of substrates by other lysosomal
hydrolases.
DISCUSSION
Despite decades of research, the culprit species and mecha-
nisms of amyloid-associated cell dysfunction and cytotoxicity
remain unclear. Many studies have focused on the early prefi-
FIGURE 5. Fragmented fibrils of 2m retain elements of amyloid structure
after internalization. A, fluorescence emission spectra of NIAD-4 in the pres-
ence of monomeric 2m or fragmented 2m fibrils at pH 7.5 and 4.5. AU,
arbitrary units. B and C, SH-SY5Y cells were incubated for 16 h with 1.2 M
(monomer-equivalent concentration) fragmented or unfragmented 2m
fibrils or 2m monomers. Prior to imaging, the cells were stained with the
amyloid-specific dye NIAD-4 and with either LysoTracker Far Red (B) to label
acidic compartments or CellMask Deep Red plasma membrane stain (C). Cell-
associated fluorescence was visualized by live cell confocal microscopy. In the
merged images, yellow indicates colocalization of NIAD-4 (green) with either
LysoTracker Far Red or CellMask Deep Red. Scale bar  10 m.
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brillar oligomeric intermediates of amyloid assembly, demon-
strating that these species are cytotoxic (6–11). Here we dem-
onstrate for the amyloidogenic protein 2m that reducing fibril
length by fragmentation enables fibrils to be internalized more
efficiently. For 2m fibrils, this results in the inhibition ofMTT
reduction and the perturbation of the endolysosomal pathway.
Therefore, 2m amyloid fibrils behave as nanoparticles whose
biological properties are dependent on their physical dimen-
sions (57, 58).
Increased access of intracellular compartments to frag-
mented 2m fibrils via endocytosis rationalizes our previous
observations of an inverse relationship between amyloid fibril
length and the inhibition of MTT reduction (34). Correspond-
ingly, the inhibition of fibril internalization with Dynasore res-
cued cellular MTT reduction. Other studies also suggest that
the endocytosis of assemblieswith an ordered-sheet structure
may be an important factor in amyloid disease, for example in
the cytotoxicity of Ure2p amyloid-like protofibrils and A1–42
oligomers (59–61); synaptic disruption induced by A1–42
oligomers (62); intracellular aggregate formation by A1–40,
-synuclein, polyglutamine sequences, and superoxide dismu-
tase-1 (63–66); and for the activation of the inflammasome by
A1–42 fibrils (67). Analogous to our observations, inhibition of
endocytosis can also protect cells against the deleterious effects
of chemical fibrils (68). Conversely, our observations also
explain why amyloid plaques are often seen as biologically inert
(13) because such large assemblies would be inefficient in
accessing intracellular compartments through endocytic path-
ways. Therefore, by affecting cellular uptake, particle size is
likely to be a key determinant in the pathological responses of
cells to aggregates formed in amyloid assembly reactions.
Despite inhibiting cellular MTT reduction, fragmented 2m
fibrils did not cause cell death. Similar observations have been
reported for microglia incubated with the amyloidogenic pep-
tide A1–42, in which MTT reduction was inhibited without
any corresponding decrease in ATP levels or lactate dehydro-
FIGURE 6. The inhibition of MTT metabolism is dependent on the internalization of fragmented fibrils of 2m. A, SH-SY5Y cells were incubated with 1.2
M (monomer-equivalent concentration) TMR-labeled fragmented 2m fibrils for 24 h in the presence or absence of 5 M Dynasore. Prior to imaging, acidic
compartments were stained with LysoTracker Green. Cell-associated fluorescence was visualized by live cell confocal microscopy. In the merged images, yellow
indicates colocalization of the TMR-labeled 2m (red) and the LysoTracker Green. Scale bar  10 m. B, the effect of Dynasore on the cellular reduction of MTT
by cells incubated with fibril growth buffer or with either fragmented or unfragmented fibrils was assayed. The percentage of MTT reduction relative to control
cells incubated with the fibril growth buffer in the absence of Dynasore was plotted. The error bars represent mean  1 S.E. over a total of 25 replicates. NS, p 
0.05; *, p  0.05; **, p  0.01. C, cells incubated with MTT were imaged by phase-contrast microscopy to visualize the reduced MTT formazan (dark staining).
Scale bar  20 m.
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genase release (69). Therefore, in some instances, the inhibition
of MTT reduction may correspond to a cellular response to
amyloid that does not result in death.Notably, the incubation of
SH-SY5Y cells with 2m fibrils coincided with the increased
production of extracellular needle-likeMTT formazan crystals.
This effect has been observed for other amyloid sequences and
has been attributed to an increase in the exocytosis of reduced
MTT formazan and the resultant inhibition ofMTT endocyto-
sis (45–47, 69, 70), which may represent an alteration in intra-
cellular trafficking pathways.
Our observation that fragmented 2m fibrils increased the
cell surface expression of the lysosomal membrane proteins
LAMP-1 and CD63, but not the total cellular content of these
proteins, provides evidence that amyloid fibrils alter trafficking
FIGURE 7. Fragmented 2m fibrils do not increase lysosomal membrane permeability. A, SH-SY5Y cells were incubated with fragmented 2m fibrils (Fib)
or 2m monomers (Mon) for up to 48 h. The cells were stained with LysoTracker Green and visualized by live cell confocal microscopy, and cell-associated
fluorescence was quantified by flow cytometry. Incubation with either 6 or 15 M sphingosine for 30 min was used as a positive control for increased lysosomal
membrane permeabilization. Scale bar  10 m. B, merged LysoTracker Green fluorescence and phase contrast images. LysoTracker Green fluorescence
detected by flow cytometry was plotted as a percentage of that of cells incubated for 0 h in the presence of 2m samples. Error bars indicate mean  S.E. over
a total of nine replicates. NS, p  0.05; **, p  0.01; ***, p  0.001. C, postnuclear supernatants prepared from SH-SY5Y cells were centrifuged for 1 h at 100,000 
g. The activity of -N-acetylgalactosaminidase in the cytosolic (supernatant) fractions was plotted as a percentage of the activity in the cytosolic and membrane
(pellet) fractions combined. As a positive control for disruption of the lysosomal membrane, Triton X-100 was added to the postnuclear supernatants prior to
centrifugation. Error bars indicate mean  S.D. over a total of four replicates.
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in the endolysosomal pathway. Because the increase in cell sur-
face LAMP-1 andCD63was dependent, in part, on new protein
synthesis, fragmented 2m fibrils may divert an increased pro-
portion of newly synthesized LAMP-1 and CD63 to the plasma
membrane instead of these proteins being sorted directly from
the Golgi to the endolysosomal pathway. Notably, loss of func-
tion of the AP-3 adaptor protein complex, which is involved in
the sorting of proteins to lysosomes, also results in elevated cell
surface expression of LAMP-1 and CD63 (71). Alternatively,
fibrils may inhibit the endocytosis of a subset of LAMP-1 and
CD63 molecules that traffic to lysosomes via the plasma mem-
brane. The notion that trafficking may be altered in amyloid
disorders is also supported by genetic studies of Parkinson dis-
ease, in which disease-associated mutations in VPS35, Rab7L1,
and LRRK2 result in Golgi and endolysosomal trafficking
defects (72, 73), whereas phosphatidylinositol-binding clathrin
assembly protein, a protein with a role in endocytosis, is amod-
ulatory factor in Alzheimer disease (74–76).
The inhibition of the degradation of ovalbumin by frag-
mented 2m fibrils provides further evidence for the perturba-
tion of the endolysosomal pathway. The inhibition of the pro-
teolysis of ovalbumin did not appear to result from damage to
the lysosomalmembrane by fragmented2mfibrils.We cannot
exclude the possibility that fibrils may cause transient increases
inmembrane permeability that were not detected in our exper-
iments, although any substantive damage to the lysosome
membrane would result in cell death (77), which was not
observed in cells incubated with fragmented 2m fibrils. More-
over, LysoTracker Green staining also suggests that fibrils do
not cause any pronounced increase in the pH of lysosomes. The
FIGURE 8. Fragmented fibrils of 2m increase the cell surface expression of LAMP-1 and CD63. SH-SY5Y cells were incubated with 1.2 M (monomer-
equivalent concentration) fragmented 2m fibrils or 2m monomers for 2 and 24 h. A, cells were fixed, permeabilized, and stained with LAMP1 and CD63
antibodies. Antibody staining was detected with fluorescently labeled secondary antibodies. Cell-associated fluorescence was visualized by confocal micros-
copy. In the merged images, images of antibody staining were combined with phase-contrast images. Yellow indicates colocalization of CD63 (green) and
LAMP-1 (red). B, cell lysates were analyzed by immunoblotting with CD63-, LAMP-1-, and GAPDH-specific antibodies. Scale bar  10 m. C, cell surface
expression of LAMP-1 and CD63 was quantified by flow cytometry and is expressed as a percentage of that of cells incubated for 0 h in the presence of 2m
samples. Error bars indicate mean  1 S.E. over a total of nine replicates. *, p  005; **, p  0.01. D, SH-SY5Y cells were preincubated for 1 h in the presence or
absence of cycloheximide and then incubated with fragmented 2m fibrils for 2 h. Cells were then stained with LAMP-1- and CD63-specific antibodies, and
antibody fluorescence was quantified by flow cytometry.
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accumulation of fibrils within lysosomes may instead over-
whelm the proteolytic capacity of this organelle. This would
explain why proteolysis of ovalbumin was reduced substan-
tially, whereas therewas a less pronounced effect on the cellular
activity of the glycosidase -galactosidase and no effect on
-glucocerebrosidase.
A reduction in the ability of lysosomes to degrade proteins
would be predicted not only to impair the degradation of endo-
cytosed soluble proteins, as shown here, but also that of mem-
brane proteins such as receptors down-regulated from the
plasmamembrane (78). In addition, the degradation of proteins
by autophagy is dependent on lysosomal proteolysis (79). The
inhibition of lysosomal proteolysis by amyloid fibrils could be a
key factor in amyloid disorders. Indeed, reduction of lysosomal
proteolysis results in an Alzheimer-like axonal dystrophy (80),
knockout of cathepsin D promotes Tau neurotoxicity (81), and
an age-related reduction in the activity of cathepsin B and D is
associated with the production of amyloidogenic fragments of
amyloid precursor protein (82). Moreover, the loss of -gluco-
cerebrosidase activity impairs lysosome proteolysis, promoting
-synuclein accumulation and neurotoxicity (83).
Impaired lysosome function may also contribute to the
pathology of dialysis-related amyloidosis, a disorder in which
2m fibrils form plaques in the osteoarticular tissues (32).
Macrophages recruited to these amyloid plaques phagocytose
2m amyloid, which then accumulates within their lysosomes
(33, 49, 84, 85). Our data predict that uptake of 2m fibrils
would inhibit the degradative capacity of these cells. Further-
more, the disruption of lysosome functionmay be related to the
inhibition by 2m fibrils of the resorption of a bone-like matrix
by osteoclasts (33), a cell type that utilizes lysosome-like organ-
elles to remodel bone (86).
FIGURE 9. Fragmented 2m fibrils inhibit the degradation of ovalbumin
by lysosomes. A and B, cells were incubated with either 1.2 M (monomer-
equivalent concentration) fragmented 2m fibrils or 2m monomers for 24 h.
Cells were washed to remove non-cell-associated fibrils, pulsed with Ova-647
for 6 h, washed to remove non-cell-associated Ova-647, and either imaged
immediately by live cell confocal microscopy (A) (0 h chase) or chased in the
absence of Ova-647 for 24 h (B). Prior to imaging, cells were stained with
LysoTracker Green. Scale bar  10 m. Cell-associated Ova-647 fluorescence
was also quantified by flow cytometry. C, representative flow cytometry pro-
files. AU, arbitrary units. D, cell-associated Ova-647 fluorescence is expressed
as the percentage of the fluorescence at 0 h chase remaining after 24 h chase.
Error bars indicate mean  1 S.E. over nine replicates performed in three
independent experiments. ***, p  0.001.
FIGURE 10. Fragmented 2m fibrils have a limited effect on the cellular
activities of -glucocerebrosidase and -galactosidase. A and B, cells
were incubated with either 1.2 M (monomer-equivalent concentration) frag-
mented 2m fibrils or 2m monomers for 24 h. Cellular -glucocerebrosidase
(A) and -galactosidase (B) activities were assayed using the fluorescent sub-
strates 5-(pentafluorobenzoylamino)fluorescein di--D-glucopyranoside and
C12FDG, respectively. As a control, cells were preincubated for 1 h with inhib-
itors of -glucocerebrosidase (CBE) and -galactosidase (phenylethyl -D-
thiogalactopyranoside (PETG)). Percent cellular activity relative to control
cells incubated with the fibril growth buffer was plotted. Error bars indicate
mean  1 S.E. over a total of six replicates performed in two independent
experiments. NS, p  0.05; **, p  0.01; ***, p  0.001.
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In summary, our observations provide further evidence that
the lysosome represents a key cellular target in amyloid disease
(87, 88) and that this organelle is readily accessible to nanoscale
amyloid fibrils produced early during amyloid assembly reac-
tions or by the fragmentation of existing fibrils. Inhibiting fibril
fragmentation and preventing fibril access to intracellular com-
partments may protect cells and provide effective strategies
toward combating amyloid disease.
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